welcome message about isop · to the 19th annual meeting of the international society of...

2

WELCOME MESSAGE

PRE-CONFERENCEPROGRAMME

04

07

ABOUT ISoP

CONFERENCEPROGRAMME

05

10

COMMITTEES

POSTER LISTING

06

20

3

COLOMBIA

TOP 10 PLACESTO VISIT IN BOGOTÁ

30

37-38

MAP

modern citiesof colombia

33-34

39-40

ABOUT BOGOTÁ

SPONSORS

35-36

41

4

Dear Colleagues,

On behalf of the ISoP Executive Committee and the Local Organizing Committee, it is our great pleasure to welcome you to the 19th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2019), “New opportunities for new generations”, in Bogota, Colombia from the 26th to 29th October 2019.

This international event on pharmacovigilance is a fantastic opportunity for professionals, researchers, students, andpatients interested in different areas and disciplines to come together with a wide variety of interesting and challenging topics, such as risk communication and management, medication errors, education, social network impact and patient perspectives, and more!

Pharmacovigilance is a fast-growing science of global interest undergoing rapid development in regions such as Latin America over the last few decades. Colombia, for example, is a country where patient safety and pharmacovigilance itself gained a privileged position on the national health agenda, thereby experiencing of multiple cases of success. Thus it isexciting to have an ISoP Annual Meeting for the third time in two decades in the region.

The ISoP 2019 meeting itself will be a venue for the convergence of ideas, topics, experiences and approaches between speakers, special interest groups and participants of the various areas of expertise. We are particularly happy to be present in this unique event and proud to have the opportunity to chair, share and exchange views, expectations and solutions with other high-level professionals, professors, colleagues and friends, representatives of well-recognized universities, institutes and organizations.

Finally, an exciting and memorable social programme will be arranged including a complimentary conference dinner in the Colombian tradition of hospitality.

We hope that you will find the meeting and your stay in Bogota both energizing and enjoyable, and we look forward to welcoming you next October!

With our Best Regards,

Sten Olsson, President ISoP

Brian Edwards, Chair Scientific Committee

Angela Caro, Chair Local Organising Committee

WELCOME MESSAGE

5

ABOUT ISoP

ISoP ADVISORY BOARDEXECUTIVE COMMITTEE

INTERNATIONAL SOCIETY OFPHARMACOVIGILANCE

BOARD MEMBERS

ANNUAL MEETINGS(ESOP AND ISoP)*

President

Vice President

Secretary General

Treasurer

Sten Olsson (Sweden)

Hilda Ampadu (Ghana)Brian Edwards (UK) Deirdre McCarthy (USA) Jan Petracek (Czech Republic) Phil Tregunno (UK) Marco Tuccori (Italy) Hervé Le Louët (France, Past President)

1993 Geneva, Switzerland1994 Rouen, France1995 Cambridge, England1996 Lisbon, Portugal1997 Berlin, Germany1998 Budapest, Hungary1999 Ankara, Turkey2000 Verona, Italy

2001 Carthage-Tunis, Tunisia2002 Amsterdam, The Netherlands2003 Marrakech, Morocco2004 Dublin, Ireland2005 Manila, Philippines2006 Liège, Belgium2007 Bournemouth, UK2008 Buenos Aires, Argentina2009 Reims, France2010 Accra, Ghana2011 Istanbul, Turkey2012 Cancun, Mexico2013 Pisa, Italy2014 Tianjin, China2015 Prague, Czech Republic2016 Agra, India2017 Liverpool, UK2018 Geneva, Switzerland2019 Bogota, Colombia

Ian C K Wong (UK and Hong Kong)

Mira Harrison-Woolrych (New Zealand)

Jean-Christophe Delumeau (Singapore)

ISoP is a global professional, independent, not- for-profitsociety, open to anyone with an interest in the safe and effective use of medicinal products. ISoP aims to foster science, learning and research in pharmacovigilance in all countries.

These objectives are met by providing:Collegial and convivial support among fellowpharmacovigilance professionals.

An open and impartial forum for sharing experience, knowledge and solutions.

A platform for discussion and generation of newresearch and ideas.Meetings, education and affordable training.

Regional Chapters and Special Interest Groups.

Opportunities for networking in a friendly environment.

ESOP Annual Meetings

ISoP Annual Meetings

6

LOCAL ORGANIZING COMMITTEE

SCIENTIFIC PROGRAMME COMMITTEE ORGANISERS

Chair

Chair

Co-Chair

Committee

Committee

Angela CARO ROJAS, Colombian Pharmacovigilance Association (Colombia)

Brian EDWARDS, NDA Regulatory Science Ltd (UK)

Angela CARO ROJAS, Colombian Pharmacovigilance Association (Colombia)

Santiago GARNICA, Colombian Pharmacovigilance Association (Colombia)Jairo CAMACHO, Colombian Pharmacovigilance Association Board (Colombia)Camilo CASTELLANOS, Colombian Pharmacovigilance Association (Colombia)Alejandra CRUZ, Colombian Pharmacovigilance Association (Colombia)Mateo JARAMILLO GARCES, Colombian Cluster Health (Colombia) Juliana RINCON JARAMILLO, Colombian Cluster Health (Colombia) Maria Laura ORDOÑEZ VARGAS, Colombian Cluster Pharma (Colombia)Miguel Angel BUSTOS URIBE, Colombian Cluster Pharma (Colombia)

Gloria P. GIRALDO, Health Canada (Canada)Linda HARMARK, Lareb (Netherlands)Katarina ILIC (USA)Carlos Enrique MALDONADO MUETE, University National of Colombia (Colombia)Neslihan MENDI, Boehringer Ingelheim (United Arab Emirates)Jayesh PANDIT, Bayer (Kenya)Djamila REIS, ARFA (Cabo Verde)Adalton G. RIBEIRO (Brazil)Victoria ROLLASON, University Hospitals of Geneva (Switzerland)Marco TUCCORI, University Hospital of Pisa (Italy)

COMMITTEES

7

Saturday October 26thPre Conference

Course 1

Medication errors and human factors.

08:00 - 08:30 08:00 - 08:30 08:00 - 08:30

10:30 - 11:00

08:30 - 09:30 08:30 - 09:30 08:30 - 09:30

09:30 - 10:30

09:30 - 10:00

10:00 - 10:45

09:30 - 10:30

Registration. Registration. Registration.

Coffee Break.

Brian Edwards

Pedro LimaNatalia Kocankova

Gloria GiraldoMariano Madurga Sanz

Gloria GiraldoCarlos Maldonado

Deirdre MacCarthyKatarina Ilic

Natalia Kocankova

Thamer Al-Shammary

SIG Group presentation:Set the scene - medication errors terms

and definitions, epidemiology.

Active pharmacovigilancefundamental aspects:

• Definitions.• Regulatory aspects: FDA,EMA

and Latam.

Global regulations on FV for biological and biotechnological (FDA, Health

Canada, EMA, ICH, WHO?)Strategies and actions taken as a result

of the regulations.Audit findings and improvement

opportunities.Industry problems to apply regulations.

* RMP and biological andbiotechnological Controversies: utility

in practice, in the clinic, in theregulatory agencies.

* The impact of different reference models,FDA vs EMA and WHO.

* Workshop.

Industry perspective Global and local.

Methods in active pharmacovigilance:

• Description• Examples

Risk factors for medication errors:what works?

Current medication errors strategies (ISMP, WHO, ASHP).

Active surveillance inpharmacovigilance includingpharmacoepidemiology tools.

Biological and biotechnological product safety.

Pre ConferenceCourse 2


11:00 - 12:00Good case management with advice about better coding and classification.

Katarina KralovaNeslihan Mendi (Support TBD)

10:30 - 11:00Coffee Break.


8


Saturday October 26th

12:00 - 13:00 10:45 - 11:15

12:30 - 13:30

13:00 - 13:45 11:15 - 12:15

11:00 - 12:00

13:45 - 15:15

13:45 - 14:15

12:15 - 13:15

12:00 - 12:30

Carlos Aceves GonzálezYordan Rodríguez

Wendy CameloStephan Jarpa

Gillian Winstanley

Wendy Camelo and All

Ghita BenabdallahHouda Sefiani

Lunch Break. Coffee Break.

Lunch Break.

Practical implications of Human Factors (The place of Ergonomic Checkpoints).

Methods in Pharmacoepidemiology.What do regulatory agencies

do with PV Databases?Do we have a room for improvement?

Naming and the duty to be of theidentification of the agent suspected of theadverse reaction and not as a commercial

strategy and applies equally to those of synthesis. Traceability, What is it?, Traceability to the patient including results in the patient’s safety, efficacy,

quality of life, adherence, etc. as a pillar in pharmacovigilance.

Practical workshop. The workshop should allow

participants to use the different methods described to enhance their

familiarity with them.

Medication error managementfrom detection to riskminimization actions. Lunch Break.

Discussion panel.

14:15 - 15:15

13:15 - 13:45

Sentinel events and analysis based on intrinsic human factors andMetacognition (Workshop).

Interactive case.

Angela CaroGhita Benabdallah

Pedro Lima

Marco Tuccori

15:15 - 15:45

13:30 - 14:30

Coffee Break.

Interchangeability and the role ofpharmacovigilance - Actual state

Experiences: How patient I am involved in the decision on interchangeability?

Switch studies.







9

PRE-CONFERENCEPROGRAMMESaturday October 26th

15:45 - 16:15

15:45 - 16:15

14:30 - 15:15

16:30 - 17:15

17:15 - 17:40

16:15 - 16:4516:15 - 16:45

16:45 - 17:15

16:45 - 17:15

15:15 - 16:00

Interactive case study: Injecting oral medicine intravenously.

(Workshop)

Hospital setting:Active Pharmacovigilance.

Interactive case.

Patient role and impact public health.

Conclusions Workshop.

Hospital experience.A successful case study of active

surveillance.

Wrap-up and Conclusions.

Wrap-up and Conclusions.(LATAM Implications, perspectives

and new tools).

Workshop feedback.

Brian EdwardsAngela Caro and All

Liliana Vargas

Marco TuccoriTo be defined

Stephan Jarpa

Gloria GiraldoMariano Madurga Sanz

Carlos Maldonado

Helaine Capucho

Carlos Maldonado

Brian Edwards

Deirdre MacCarthyNatalia Kocancova

All









Welcome Cocktail Dress code: Casual

10

Sunday October 27th

08:00 - 09:00

09:30 - 10:30

11:00 - 11:45

11:45 - 12:30

10:30 - 11:00

12:30 - 14:00

08:30 - 09:30

Register.

Patients in Pharmacovigilance.

Importance of Human factors in pharmacovigilance.

ENCEPP talk: assessing the impact of pharmacovigilance and interventions to minimise risk.

Break

Lunch for Delegates*Reserved area SIG Meetings*

OPENING SESSION.Sten Olsson (President of ISoP)Brian Edwards (UK) Chair ISoP 2019Angela Caro (Colombia) Co Chair ISoP 2019 Prof. Carlos Maldonado (Colombia) Claudia Vaca (Colombia)Marie Lindquist (UMC)Shanti Pal (WHO)

Helen Haskell / Evangelina Vásquez

Carlos Aceves González / Yordan Rodríguez

Agnes Kant

CONFERENCE PROGRAMME

11

Sunday October 27th

14:00 - 14:30 14:00 - 14:20

14:30 - 14:50 14:20 - 14:40

14:50 - 15:10

15:10 - 15:30

Parallel session A

Current approaches to Traditional Chinese Medicines(China)

Theater in indigenous populations andPharmacovigilance.

Cannabis products: pharmacological andpharmacovigilance challenges.

Vigilance of cannabis products in Canada.

Abstract oral presentation:

#52 - Current status and thoughts about heart injuryrelated to Traditional Chinese Medicine.

Abstracts oral presentation: #87 - Systematic Instructions for Haematological

Monitoring in Summary of Product Characteristics– what constitutes good practice.

#19 - MedSafetyWeek:joining forces on social media to raise

ADR awareness.

Herbal and traditional medicines SIG.

Safety issue communication requirements.

Open Discussion.

Importance of Communication inPharmacovigilance.

Parallel session B

15:30 - 16:00 Break

Coordinator: Jo Barnes

Katarina Ilic

Stephanie Jack (Health Canada)

Dr. Jia-bo Wang

Coordinator: Ulrich Hagemann

Juan Miguel Palacios (Teleconference)

Gillian Winstanley

CONFERENCE PROGRAMME

14:40 - 14:55

14:55 - 15:10

15:10 - 15:30

12

16:00 - 16:30 16:00 - 16:30

17:05 - 17:20 17:05 - 17:20

Feedback on UMC seminar about vaccine safety.


#91 - Vaccines safety in children and in generalpopulation: a pharmacovigilance study on

adverse events following immunization in Italy.

Transcelerate projects in PV.

Abstract oral presentation:#143 - Creation of an Innovation Function in

Pharmacovigilance.

What’s new from North America and EU? Safe use of Vaccines.Chair: Gloria Giraldo

José Vega

José Vega, Fabio Lievano, Félix Arellano

Rebecca Chandler

Alex Dodoo

Chair: Houda Langar

16:30 - 17:05 16:30 - 17:05

Panel Discussion. Progress with malaria vaccine.

17:30 - 18:00 Musical show at the hotel.

Parallel session C Parallel session D

Sunday October 27thCONFERENCE PROGRAMME

13

08:30 - 09:00 08:30 - 09:00

09:00 - 10:00 09:00 - 10:00

Parallel session E


Risk management and Signal detection.

PV Education experience of LATAM.Symposium.

Digital approaches to risk minimisation.

Biotechnological and biosimilars drugs.

Challenges in Latin-American Pharmacovigilance.

Parallel session F

10:00 -10:30 Break

Chair: Jean-Christophe Delumeau Chairs: Luis Alesso / Raquel Herrera

Jorge Machado, Adalton Ribeiro (TBD),Raquel Herrera and Luis Alesso

Chair: Marco Tuccori Pedro Lima, Gillian Winstanley, Fabio Lievano.

Mark Perrott

#14 - Application of Qualitative method to detect signals and manage alerts in pharmacovigilance: Moroccan

experience.

#29 - Digital tools for the communication of riskminimization measures for medicines.

Discussion.

Monday October 28thCONFERENCE PROGRAMME

14

11:45 - 12:30

Parallel session G

Expert Panel discussion on women’s medicines.


#147 - How the Romanian women perceive theadvantages and risks of the contraceptives?

Parallel session H

10:30 - 10:35

10:35 - 11:10

11:10 - 11:30

11:30 - 11:45

10:30 - 11:30

Welcome and introduction.

International overview of long-acting reversiblecontraceptives (LARCs) for women.

Teleconference.

Mifespristone introduction experience.

Medicines for Reproductive Health:International and local perspectives for

Latin American Women.

Panel.

Desafios de la farmacovigilancia “Spanishcommunity” España, Latam y SC in USA.

Chair: Mira Harrison-Woolrych

Dr. Mira Harrison-Woolrych

Prof. Sam Rowlands

Ulrich Hagemann, Raquel Herrera,Katarina Ilic, PROFAMILIA representative

PROFAMILIA: Juan Carlos Vargas,Fidel Ramírez, Andres Reyes

Chair: Angela Caro / Mariano Marduga

Evangelina Vasquez (Patient vision), Pilar Lagos (Regulatory)Elki Sollenbring (UMC)

Stephan Jarpa (Public Health and Pharma Industry)Wendy Camelo (Pharmacoepidemiology)

Claudia Vaca (WHO)Liliana Vargas Neri (Hospital Vision)

Open panel with public.

Abstracts oral presentation.

11:30 - 12:00

12:00 - 12:30

#37 - Impact and Characterization of the DrugRelated Problems Reported by Polymedicated Inpatients

with Prolonged Stays.

#46 - Initiative to increase PV awareness and supportaccess to medication for the patient.


15

12:30 - 13:30 Lunch for Delegates*Reserved area Chapter Meetings*

13:30 - 14:45 ISoP GENERAL ASSEMBLY.

1. Welcome and approval of Agenda and Minutes General Assembly Geneva.

3. Financial position and membership fee for 2020

5. ISoP Advisory Board Elections 2019.

2. Fellowship awards

4. Highlights since Geneva (governance, partnership, meetings, chapters and SIGs).

6. Planning for the future.

7. Any other business.


16

15:30 - 16:00 15:30 - 16:00

Abstracts oral presentation: Abstracts oral presentation:

14:45 - 15:30 14:45 - 15:30

Parallel session I

Brazil:

Mexico:

Latin America perspective:

Asia:

Industry Contribution to the developmentof effective global and national

pharmacovigilance systems.

Impact in real life: are we making a difference? (Hospital/community vision)

Parallel session J

Chair: Katarina Ilic

Helaine Capucho

Liliana Vargas Neri

Gillian Winstanley

Jean-Christophe Delemeau

Chair: Marco Tuccori

#59 - Patient counselling practice among healthcareprofessionals in Saudi Arabia: its impact on patient safety.

#129 - Differences in Pharmacovigilance RegulatoryRequirements in Latin America countries (LATAM).

#110 - Medication errors and genetic factors aspossible causes of therapeutic failures and

adverse drug reactions in a group of Colombian epilepsy patients.

16:00 - 16:20 Coffee


17

16: 20 - 17:00

Chapters Session

Africa Chapter.

North American Chapter

Middle East:

Latest news about ISoP Chapters.Chair: Brian Edwards

Sten Olsson

Veronique Kugener

Thamer AlShammary

Italy Chapter: Marco Tuccori

South East Europe:

Pacific Rim Chapter:

Indonesia:

Katarina Ilic

Mira Harrison-Woolrych

Jean-Christophe Delumeau


18

17:00 - 17:40

Special Interest Group Session

SIGs Risk Communication, Medication Errors, Women’s Medicines GroupRisk Minimisation Methods for Asian countries, Herbal and Traditional Medicines,

PV Professional Qualification Framework, Medical Devices.

What SIGs exist, why and how can I join a SIG?Chair: Deirdre Mc Carthy

20:00 - 24:00 Gala Dinner.

19:00 - 19:30 Transportation to the Gala Dinner venue.

Dress code: Casual-Formal


19

09:00 - 09:30

10:00 - 10:40

11:00 - 11:45

10:40 - 11:00

12:30 - 14:00

09:30 - 10:00

Strengthening the capacity for signal detection and management for national centres.(Uppsala Monitoring Centre).

Smart Safety Surveillance: what, why and how.

CIOMS Update about hepatoxicity and DILI - Lecture.

Break

Lunch

Bengt Erik Wiholm Lecture.Which are the new opportunities for new generations?

11:45 - 12:30 Posters and abstracts awards. Host presentation for ISOP 2020 in Oman

Mariano Madurga Sanz

Dr. Birgitta Grundmark

Shanti Pal

Hervé Le Louët

Thamer M. AlShammary

Tuesday October 29thCONFERENCE PROGRAMME

20

POSTER LISTING

147 posters have been successfully accepted for this year’s 19th ISoP Annual Meeting. Posters will be displayed in theexhibition hall area on Sunday and Monday. Poster judging will take place during the conference and the three best posters will be awarded during the poster prize ceremony on Tuesday October 29- 14 from 11:45 to 12:30. Presenting authors are kindly requested to be present throughout the official poster viewing times (as specified above) but due to the large numberof posters, the Poster Committee will not only view the posters during the official sessions but during the conference on Sunday and Monday.

Official poster session times are:

Assistance for poster mounting / dismantling will beavailable at the Poster desk located in the exhibition hall area.

Sunday October 27, 2019 Monday October 28, 2019

Posters 1 to 37 from 10:30 to 11:00 Posters 76 to 113 from 10:00 to 10:30

Posters 38 to 75 from 15:30 to 16:00 Posters 114 to147 from 16:00 to 16:20

Poster Viewing Schedule / Discussion time with Poster Committee

POSTER PRESENTATIONS

#

1

2

3

5

TITULO / TITLE

The current status of korea institute of Drug Safety and risk management -Korea adverse event reporting system database in the republic of Korea.

Antibiotic Drugs and unresolved sensory side effects: analysis of eudravigilance database of suspected adverse drug reaction reports.

Impact on the detection of DRPs when including technical staff within the pharmacoterapeutic monitoring program in the pharmaceutical service.

Integrated use of spontaneous reports od adverse drug reactions and observa-tional healthcare data in signal assessment.

AUTORES /AUTHORS

PAÍS /COUNTRY

J.A. Correa Narvarte COLOMBIA

S.Shin/S.Oh, B.Kim, B.Jang, D.Kim, H.Kim, S.Y.Chung KOREA

M.Tuccori/ S. Ferrano, L.Leomardi, C.Blandizzi, I.Corventino ITALY

P.Ryan /R.Chandler SWEDEN

21

POSTER LISTING

#

6

7

8

9

10

11

12

13

15

16

TITULO / TITLE

Acivity report of the pharmacovigilance unit of the ibn sina rabat hospital:National pharmacovigilance notification day 23nd may 2019.

Upper Gastrointestinal Bleeding and Risk Factors.

Drug Interactions through active pharmacovigilance in an internacional medicine emergency service of a Tertiary Care Hospital: A Cross Sectional Study.

Adverse drug reactions related to extemporaneously compoundedmedicines.

Anticoagulant therapy and risk of bleeding in patients with atrial fibrillation of four italian regions: The TYRION study.

Online discussion forums in bulgaria as a source of adverse drug reactions reports for sertraline.

The role of the clinical pharmacist in the detecting of suspected ADR in asecondary level hospital.

Survey of healthcare professionals on Adverse Drug reaction reporting,communication, and medicines regulation in New Zeland.

Indication of use of omeprazole in Elderly Patients with Alzheimer disease.

Minimization of the risk after and intervention in a cohort of patients withdispensation of diacerein oral in two colombian areas 2018-2019.

20 Impact of pharmacovigilance education on adverse drug reaction reporting among nursing staff at a major tertiary hospital in riyardh, Saudi Arabia.

AUTORES /AUTHORS

PAÍS /COUNTRY

P Carvalho Mastroianni/M.T.Herdeiro, M.Forgerini,

G. Schiavo, T. De Nadai, G. Urbano, M.Zapata, A.Guzman

PORTUGAL

P.Manosalva Rojas /S.Arias Villate/D.Forero Bernal/

J.Cardenas-roldanCOLOMBIA

Conventino/L.Leonardi/M.Tuccori/S.Ferraro/S.Salvadori/M.Franchini/I de

Carlo/U.Kirchmayer/T.Corona/S.Riengler/E.Menditto/M.Parrilli/M.

Rossi/V.Orlando/S.Pieroni/ A.Vannacci

ITALY

H.Lebanova/ E.Grigorov/K.Tonev BULGARIA

I.CHAN/S.Kenyon NEW ZEALAND

H.Daoudi MOROCCO

F.Rossi Varallo/P.Mastroianni,M.Forgerini.

D.Dazapaz, Y.C.Paz,E.H.Fajardo Romero

E.A.Alghamdi

BRAZIL

COLOMBIA

SAUDI ARABIA

PSK Takahashi/MCS Ricci/MLB Yanagita/AM YAMAGUCHI/

Dal-pazBRAZIL

G. De Freitas Santana /M.Massae Toma/T.Rubens de nadai/J.Richard de Lima Benzi/

P.de Calvalho Mastroianni

BRAZIL

21

22

Communicating the venue of pharmacovigilance above and beyondcompliance.

Recommendations by the tuscan health authority to use infliximab-biosim-ilar in the clinical practice: Safety Impact.

A.Shah/A.corrado/E.mingle/L.Oshea/ L.Wagman/R. Di Menno/

R.Morckute/ S.Beauchamp/J.Freeman/D.Abatemarco

I.Convertino, E.Lucenteforte,V. Lorenzoni, G,Turchetti, L.Trieste,

G.Roberto, M.cazzato, M.Mosca, S.Ferraro, L.Leonardi, N.Luciano,

R.Gini. C.Blandizzi, M.Tuccori

SWITZERLAND

ITALY

23 Retrospective study of adverse effects of drugs: Experience of the regional pharmacovigilance unit of the University Hospital Hassan II of Fez, Morocco.

I.Imane, T.Amina, S.B.Rachida, A.Sanae

MOROCCO

22

POSTER LISTING

#

24

25

26

27

28

30

31

32

33

34

TITULO / TITLE

Drug label changes throught serious adverse event review system in theRepublic of Korea

Effect of the pharmacists in antimicrobial stewardship (AMS) Programs in a high complexity Hospital in Colombia between 2016-2018.

Medications storage knowledge, attitude and practice among diabeticpatients and their association with blood glucose control.

Online discussion forums in bulgaria as a source of adverse drug reactions reports for omeprazole and famotidine.

Disproportionality Analysis in small national database: Robust results butquestionable utility.

Risk and signals of Urinary tract infections among sodium-glucosecotransporters 2 (SGLT2) Inhibitors: Analyses of post Marketing FDA adverse event reporting system (FAERS) database, 2013-2018.

Fast, robust and flexible statistical screening of national subsets in Vigibase throught vigiLyze.

Colistion induced nephrotoxicity in adult population during intrevenous therapy.

Pharmacovigilance of antivenoms in toxicological emergencies.

Obtaining real time estimates of commercial patient exposure.

35

36

HPV Vaccination Program in Romania-Strategies and Results.

Potential adverse drug events in elderly patients.

AUTORES /AUTHORS

PAÍS /COUNTRY

S.M.Shin, S.Y. Chung, H.Kang, A.Y.Suh,M.Kim, B.G Kim, Y.Park,

Y.Kim, J.Won

N.P. Martinez/C.Pallares/A.Rivera/M.Villegas

A.Altebainawi, M.Alrashdi,M.Alshammari, T.Alshammari

H.Lebanova/ E.Grigorov/K.Tonev

B.Grundmark, O.Caster, Y.Aoki, L.Gattepaille

T.M. Alshammari/F.Alnofal/S.Ita/M.Alotaiby

H.Sköld

D.C. Zapata Cristancho/ H.Restrepo Guerrero

N.Velazquez Angeles

D.Bernasconi, K.Deb, H.Wang,K.Anstatt, A.Gadit, S.Tepper,

M.Wiener, J.Freeman

A.Butuca, C.Morgovan,L.Vonica-Tincu, A.Chris, F.Gligor,

A.Juncan, A.Muntean, A.Pecnejer

X.Lagos, L.Villa, C.Contreras,R.Scheid, C.Caro

KOREA

COLOMBIA

SAUDI ARABIA

BULGARIA

SWEDEN

SOUTH ARABIA

SWEDEN

COLOMBIA

MEXICO

USA

ROMANIA

CHILE

38

39

Safety of inulin: combining several sources for Pharmacovigilance purpose.

Impact of the pharmacist’s intervention in the standardization of the dose of Metamizole as perioperative analgesic.

T.Bui, M.Courbebaisse, D.Prie, C.Le Beller, A. Lillo de Louet

O.D. Arias Romero, M.Juaregui Acuña, K.Charria Lievano

FRANCE

COLOMBIA

23

POSTER LISTING

#

40

41

42

43

44

45

47

48

49

50

51

TITULO / TITLE

A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies.

Evolution of Communication Plan REMS Programs.

Tramadol and Hyponatraemia – new aspects of an old signal.

Fluoroquinolones and risk of tendinopahty: a systematic review and me-ta-analysis of observational studies.

Activity report of hospital pharmacovigilance: case of the National Institute of Oncology of Rabat.

Indapamide-induced (acute hypokalemic) rhabdomyolysis.

Interest of a bidisciplinary collaboration: Experience of 4 month dermatology-pharmacovigilance consultation.

Local tolerance during administration of two brands of subcutaneoussomatropin.

REMS Technology Innovation: Results of a Pharmacy Business to Business (B2B) Pilot.

Vigilance of Cannabis Products in Canada.

Drug-problems in a newborn neonatal intensive care unit in II level hospital in Bogotá during a period of 6 months.

53

54

A pilot intensive safety surveillance scheme for medicines under additional monitoring used in the treatment of cancer.

Promoting Spontaneous Adverse Event Reporting in Morocco: The national Reporting Day.

AUTORES /AUTHORS

PAÍS /COUNTRY

C.Alves, D.Mendes,F.Batel-Marques

M.L.Chan Liston, D.L.H Mai, J.Bourke, R. Mc Williams, T.Berry,

P.Sheehan, J.Freeman

B.Grundmark, S.Hult

D.Mendes, F.Batel-Marquea

A.A. Casimir, M.Lazrak,A.Tebaa,A.El Fassi, Y.Rahali

Q.Y. Yue

P.Sanchez Peria, B.Milpied

S.Vencio, D.Morais, K.Barbosa, M.F.Amato, G. De Mendonca

T.MC.Williams, P.Sheehan, J.Freeman, J.Bourke, M.Chan -Liston, J.varandas, C.Marino,

K.White

S.Jack

C.J. Pino Pinzon

A.Pendones, D.Mendes,G.Rigueiro, F.Batel-Marques,

C.Alves, R.Sousa, G.Sousa

R.Soulayman, H.Sefiani,G.Benabdallah, A.Tebaa

PORTUGAL

USA

SWEDEN

PORTUGAL

MOROCCO

SWEDEN

FRANCE

BRAZIL

USA

CANADA

COLOMBIA

PORTUGAL

MOROCCO

55 Knowledge, attitude and perception of medicine students with respect to the use of antibiotics and their resistances.

N.Nogueira, M.Zapata, P.Lopez, J.Vazquez, M.Herdeiro,

A.FigueirasSPAIN

24

POSTER LISTING

#

56

57

58

60

61

62

63

64

65

66

67

68

TITULO / TITLE

Use of social media in pharmacovigilance for patient empowerment andspontaneous reporting: a systematic review.

Acute pulmonary edema in pediatric oncology: pharmaceutical vigilance.

Identification of communication opportunities in the report process of adverse reactions.

Adverse reactions associated with the use of biotechnological drugs inColombia.

Monitoring of adverse drugs reactions through statistical process control charts in the National Institute of Cancerology of Colombia.

Fluoroquinolones and tendon ruptures: An analysis of reported cases in rela-tion to exposed patients in Germany.

Green urine after propofol infusion.

Update of pure red cell aplasia associated to Hemax®, a biosimilar epoetin alfa.

Materiovigilance in a pediatrics hospital: about two cases.

Develop a semantics & graph based Pharmacovigilance knowledge man-agement approach to enable data mining and decision support.

Parkinsonism associated with Gabapentinoid drugs: an observational post marketing study.

Description of adverse reactions found in patients who received Voricona-zole in the University IPS from the period of May 2013 to March 2015.

69

70

Lessons learned from a fatal medication error related to Rocuronium in anewborn, 2018, Morocco.

How Portuguese users of social media communicate with Pharmacovigi-lance Unit Facebook pages?

AUTORES /AUTHORS

PAÍS /COUNTRY

S.Ajaude, F.Varallo, L.Pererira, J.Lopes

A.C.Adade, H.Attjioui, A,Cheikh, A.Tebaa, M.Bouatia, H.Mefetah

C.Carvalhol, B.Consani, G.Rafaini Lloret, I.Miguez de

Almeida

C.Moran Yela/ J.Machado-Alba/ A.Jimenez Morales

W.S.Medina, Ospina Martinez, Palomino Ramirez,C.Aristizabal-niño

U.Köberle, L.Prause, T.Stammschulte, U.Gundert,

M.Pitzer, L.Niepraschk

O.Elhamdaoui, C.Rhaymi,H.Meftah, R.Rachida, A.Tebaa

L.Musfelda, R. Di Vita, H. Ferro, E.Gonzalez, R.Diez, M.F.Amato,

M.Richelme

H.Mefetah, M.Bouatia, A.Tebaa, H. Attjioui, A. Cheikh, Z. Aliat,

I,Bennani

S.Desai, S.Negpal, E.Mingle, N.Tetarenko, B.Assuncao

T.P.Pacheco

N.Angulo

R.Soulaymani, L.Alj

T.HERDEIRO,A.Duarte, F.Roque, V.Roque,

BRAZIL

MOROCCO

BRAZIL

COLOMBIA

COLOMBIA

GERMANY

MOROCCO

ARGENTINA

MOROCCO

USA

COLOMBIA

COLOMBIA

MOROCCO

PORTUGAL

25

POSTER LISTING

#

71

72

73

74

75

76

77

78

79

80

81

83

TITULO / TITLE

Use of escitalopram associated with mastalgia in a middle-aged woman with generalized anxiety disorder: a case report and literature review.

The Impact of New Chemical Entity Project on Signal Detection in Saudi Arabia.

Drug-related problems surveillance inside San VicenteFundacion Hospital.

Cost of Potentially Inappropriate Medications in French Regional Residen-tial Care Homes for Elderly.

Post-marketing evaluation of SC interferon beta 1a (Blastoferon®) inArgentina.

Develop an Emergent Behavioral Capability model to enable Transforma-tional Programs in Pharmacovigilance and beyond.

Anti-tumor necrosis factor drugs and risk of lymphoma in patients withinflammatory bowel disease.

Listening social media for pharmacovigilance objectives: which usefulness?

Therapeutic Drug Monitoring in Morocco: experience of Centre Anti Poison et de Pharmacovigilance.

Bleomycin-induced flagellate erythema: A case series of twelve patients.

Seasonal Influenza Vaccination: Knowledge, Attitudes and Behaviors inPregnant Women and Health Care Professionals - Morocco, 2018.

Analysis of the recording of a history of drug allergies and adverse drugreactions in routine prescribing practice in a UK teaching hospital.

84

85

Establishing dose-banding limits for children’s medications.

Pharmaceutical analysis of handwritten medical prescriptions from doctors in pediatrics hospital.

AUTORES /AUTHORS

PAÍS /COUNTRY

C.A. Currea, A. Cotamo

M.Almehaijeen

R.A.Calvo, N.Valencia, D.Mesa

H.Bagheri, J.Montastruc,M.Caucat, A.Zacarin, V.Rousseau

L.Musfeldt, M.Amato, H.Sotelo, A.Carra

S.Desai, S.Powell, O.White-house, E.Mingle

C.Blandizzi, M.Tuccori,D.Ferraro,L.Leonardi,

I.Convertino

C.Blandizzi, M.Tuccori,D.Ferraro,L.Leonardi,

I.Convertino

L.Ait Moussa, A.Tebaa,R.Soulayami

A.Chaibi, B.Moukafih,H.Abahssain, M.Snow, H.Mrabti,R.Benchaikh, A.Tebaa, H.Errihani

L.Alj, I.Cherkaou,H.Aoufi,A.Khattsbi, M.Sadar,A.Ezzahidi,

H.Ezzine, M.Youbi

J.Coleman, C.Anton, Y.Nampijja, K.Badyal, R.Ferner

A.N.Rashed, S.Tomlin

H.Attjioui, Z.Aliat,A.Tebaa, H.Mefetab, M.Bouatia,

A.Cheikh, C.Adade

COLOMBIA

SAUDI ARABIA

COLOMBIA

FRANCE

ARGENTINA

USA

ITALY

ITALY

MOROCCO

MOROCCO

MOROCCO

UK

UK

MOROCCO

26

POSTER LISTING

#

88

89

90

93

94

95

96

97

98

99

100

TITULO / TITLE

Pharmacovigilance teaching in Brazilian Public Universities.

Drug-related problems in older patients - a pilot study in Portuguese pri-mary care centers.

Pilot study for Bulgaria addressing medical doctors and pharmacistsperceptions for medicines reclassification safety issues.

Patients’ Knowledge of ADR and its notification in Colombia: a quantitative study.

Medication errors patient reporting assessment within Moroccanpharmacovigilance database.

Impact of a robust team of pharmacists in the active pharmacovigilance of a public university hospital in Bogotá.

Drug-related incidents involving children in Brazilian University Hospitals.

Knowledge, Attitude and Practice of Health Professionals towardsPharmacovigilance in Women.

A Biological Network Convergence Approach for Interpreting Herb-DrugInteraction-Related Adverse Reactions.

Educational intervention for the strengthening of the capabilities of healthprofessionals in Pharmacovigilance for the application of the regulatoryframework in El Salvador.

Using a mobile-phone based system for surveillance of adverse events in the roll out of dolutegravir: a pilot project.

101

102

Leveraging big data techniques to support medical review inpharmacovigilance.

Characterization of adverse drugs events in elderly identified in a hospitalbetween 2017 and 2018, in Bogotá, Colombia.

AUTORES /AUTHORS

PAÍS /COUNTRY

F.Dias, H.Carneiro, I.De Medei-ros, M.Ramos, V.Viana

M.T.Herdeiro, F.Roque, E.Marques, A.Placido,F.Lima, P.Mastroianni, I.Fernandes,

D.Gomes

E.Grigorov, H.Lebanova, V.Belcheva

A.J.Saavedra Espitia, L.Ospina Fonseca

R.Soulaymani, L.Alj,G.Benabdallah, H.Sefiani,

A.Tebaa

Bodensick Cuervo

H.Carneiro, R.santos, R.Mota, F.Dias

R.Karki

J.Wang, X.Zuo, X.Quin, Y.Zhang, X.Wang, M.Sha, J.Hao,M.Niu,

H.Hu, J.Liu, X.Liu, H.Liu, X.Xiao

M.A CAMPOS

S.Namanda

N.Tetarenko,S.Desai, H.Kuzucu,V.Sukaitiene, E.Mingle

M.Muñoz/ L.Mursia

BRAZIL

PORTUGAL

BULGARIA

COLOMBIA

MOROCCO

COLOMBIA

BRAZIL

NEPAL

CHINA

EL SALVADOR

UGANDA

SWITZERLAND

COLOMBIA

86 Use of triggers tool to detect adverse drug reactions in an adult emergency department at a Brazilian University Hospital.

S.Gueiros, P.Sayuri, L.Mendes, F.Rebello BRAZIL

27

POSTER LISTING

#

105

107

108

109

111

112

113

114

115

TITULO / TITLE

Active Pharmacovigilance to determine delayed adverse drug reactions inMexican childhood cancer survivors.

Improved Pharmacovigilance in management of late-onset side effects.

Regulatory landscape of pharmacovigilance in Latin America. Comparative review of the pharmacovigilance regulation in LATAM countries versusInternational Standards from ICH.

Risk management in drug interactions.

Establish active pharmacovigilance network based on common data model in Korea: Safety evaluation of NOACs.

Effectiveness and safety of standard and reduced dose rivaroxaban com-pared to vitamin K antagonists in patients at high risk of bleeding or stroke.

Performance of sodium polystyrene and serum of potassium levels as trig-gers to detect drug-induced hyperkalemia.

Active monitoring of newly standardized medication with less than five years in commercialization.

A Protocol for systematic review of Guidelines for antibiotics prescription in respiratory tract infections.

117

118

119

Cardiac Toxicity of Trastuzumab in Non-Metastatic Breast Cancer HER2 Pos-itive – The Experience of County Oncology Clinic Sibiu, Romania.

Example of the contribution of pharmacogenetics to pharmacovigilance inMorocco: Prevalence of the CYP2C19*2 polymorphism and Clopidogrel resist-ance in Moroccan population.

Analysis of Traditional Chinese Medicine Safety Information Issued by China Adverse Drug Reaction Information Bulletin.

AUTORES /AUTHORS

PAÍS /COUNTRY

J.Vargas Neri, V.Martínez, P.Clark, N.Ortega, G.Hernández,

E.Ruiz,F.Hernández

B.Grundmark

M.fredy/g.alejandra/C.ana/b.jenny/g.poveda

D.Lopez/D.Cardona/E.Osorio

D.Kang, M.Kang

N.Moore

F.R.Varallo, M.Vborges,P.Mastroianni, T.Nadai

I.Miguez de Almeida, B.Con-sani, D.Cecilia,

T.Herdeiro, D.Gomes,F.Roque, I.Oliveira, C.Costa, G.Maio

A.Chis, B.Valeanu, A.Butuca,L. Rus, F.Gligor, C.Dobrea

A.Lamzouri,A. El Rherbi,H.Sefiani, G.Benabdallah,

A.Tebaa, R.Soulaymani, A.Sefiani

T.Guan, W.Li, X.Yang, J.Cong

MEXICO

SWEDEN

COLOMBIA

COLOMBIA

KOREA

FRANCE

BRAZIL

BRAZIL

PORTUGAL

ROMANIA

MOROCCO

CHINA

103

104

A Rational Usage of Combined Using of Herbal Medicines and SyntheticMedicines: A Time Interval Window Research.

Interception and management of medication errors at the pharmacy of Ibn Sina Hospital Rabat - MOROCCO: Case of a fatal error.

J.Wang, X.Quin, Y.Zhou, X.Wang, J.Hao,M.Niu, H.Hu, J.Hao, X.Xiao, H.Hu, X.Xiao

H.Daudi

CHINA

MOROCCO

28

POSTER LISTING

120

121

122

Use of antipsychotics for Psychological and Behavioral Symptoms ofDementia in elderly with Alzheimer’s disease.

A Model for Federated, Near Real-Time Individual Case Safety ReportCompliance Monitoring.

Adverse effects induced by imatinib (Cémivil®): About 4 cases at Ibn sinahospital in Rabat.

M.Forgerini,J.C.Fernandes,MT.Herdeiro, Pde Carvalho

K.Douglas, E.Mingle,N.Tetaren-ko, D.Abatemarco

S.Yanisse, H.Daouda, A.Tebaa,M.Ait,

PORTUGAL

USA

MOROCCO

#

123

124

125

126

127

130

131

132

133

TITULO / TITLE

Use of medicinal plants in oncology and their adverse effects.

The anti-TNF drugs and the risk of lymphoma, skin cancer and melanoma: a signal detection analysis.

Severe cutaneous adverse reactions (SCARS): the analysis of drug injury relief applications in Taiwan.

ADHD Medications and Psychotic Disorders.

Overview of Pharmacovigilance System in Colombia: Present and principal challenges.

Gender-related differences of adverse drug reactions in the Moroccanpopulation.

Smuggling in Morocco: a real public health problem.

Proposal of an exclusive pharmacovigilance discipline for health sciencecurricula in Brazil.

Neonatal Drug Withdrawal Syndrome and Gabapentinoids.

134

135

Cutaneous adverse drug reactions in a third level center: an activepharmacovigilance institutional program in Colombia.

The Analysis and Enlightenment of DSMB Application in Pediatric DrugsClinical Trials.

AUTORES /AUTHORS

PAÍS /COUNTRY

S.Yanisse, A.Benomar,M.Bouatia,A.Tebaa

L.Leonardi, M.Fornili, I.Convertino,E.Lucenteforte,M. Del Lungo,

S.Ferraro, C.Blandizzi, L.Giovannetti, L.Baglietto,M.Parrilli, V.Borsi,

D.DI Giorgio

M.Chien, P.Chao,W.Chen

H.Duran, D.Macias, G.Giraldo, J.Castro, R.Tabares

S.Arias, T.Pacheco, M.Avila,A.Cotamo, R.Bustos


A.Cheikh


A.Cheikh

F.Varallo, R.Rascado, L.Pereira, N.Silva

D.Macias, H.Duran, G.Giraldo, J.Castro, R.Tabares

S.Arias, J.Manosalva, S.Amaya, S.Alvarez, M.Arias, W.Briceño

L.Zhang, J.Huang, Y.Wen

MOROCCO

ITALY

TAIWAN

SPAIN

COLOMBIA

MOROCCO

MOROCCO

BRAZIL

SPAIN

COLOMBIA

CHINA

29

POSTER LISTING

136

137

138

139

French Levothyrox® Crisis: Retrospective Analysis of French web forumsdedicated to thyroid pathology.

Pharmacovigilance risk assessment to radiopharmaceuticals.

Acute generalized exanthematous pustulosis (AGEP) inducted by penicillin.

Safety of drug packaging: a risk management plan is needed.

M.Benkekit, B.Auden, C.Grouin, P.Zweigenbaum,C.Bousquet,

M.Jaulent, A.Lillo Le Louet

E.Grigorov, H.Lebanova,T.Tsvetelina

S.Yanisse, M.Mabrouki, M.Ait, A.Tebaa

A.Tebaa

FRANCE

BULGARIA

MOROCCO

MOROCCO

#

140

141

142

144

145

146

147

TITULO / TITLE

Cardiovascular adverse drug reactions of ibrutinib, idelalisib, acalabrutinib and venetoclax used in chronic lymphocytic leukemia: Signal detection bydisproportionality analysis from VigiBase®.

Piperacillin-Tazobactam induced Neutropenia: Report of 4 cases and review of the Literature.

A Study of the Causality, Severity and Preventability of Antibiotics Adverse Drug Reactions Reported to the Iraqi Pharmacovigilance Database(2010-2017).

Terlipressin induced Hyponatremia: Report of 3 Cases and description ofassociated risk Factors.

Trastuzumab emtansine induced acute pancreatitis: report of two cases and review of literature.

Drug-associated anaphylactic shock: the analysis of drug injury reliefapplications in Taiwan.

How the Romanian women perceive the advantages and risks of thecontraceptives?

AUTORES /AUTHORS

PAÍS /COUNTRY

T.P.Pacheco, C.Conte

G.A.Keller, L.Wachs, I.Bignone, G.Di Girolamo, R.Diez

M.Mohammed, A.Al Charakh



W.Chen, M.Chien, P.Chao

C.Morgovan, A.Butuca,I.Lupse, A.Juncan, F.Gligor, A.Vonica - Tincu, L. Rus, A.

Muntean, S.Ghibu

FRANCE

ARGENTINA

IRAQ

ARGENTINA

ARGENTINA

TAIWAN

ROMANIA

30

COLOMBIA

COLOMBIA

ABOUT BOGOTA

Is a diverse country thanks to its culture, geography and history, which offer unique and authentic tourism experiences. Experiences that makes you travel through time, between colonial architectures and modern cities, indigenouscommunities and an incredible natural biodiversity; among fairs and festivals that express traditions and a diverse (and delicious) regional gastronomy. Therefore, if you want to fall in love with a country that offers different experiences every day, visit Colombia.

Bogota is the capital and largest city in Colombia. A melting pot of people from around the country, it is diverse and multicultural, with a blend of modern and colonial architecture. The predominant colors in Bogotá are the green of the city’s many parks and the eastern mountains overlooking the sanctuaries of Monserrate and Guadalupe, and the rich red of its many brick buildings. In Bogotá travelers have access to a range of entertainment that includes around 50 museums, plus fine dining, lively nightlife, and nearby nature reserves.

31

COLOMBIA

LANGUAGE VACCINATION

ENTRY MONEY AND GOODS

WATER CONSUMPTION

INSURANCE

The official language is Spanish. You must be vaccinated against yellow fever at least 10 days before departure to these areas:

• The departments of Amazonas, Caqueta, Casanare, Cesar, Guainia, Guaviare, Guajira, Meta, Putumayo, Vaupés and Vichada, where more than 80% of municipalities are classified as high risk.

• The Department of Magdalena: The district of Santa Marta and the municipalities of Ciénaga and Aracataca.

• The department of Norte de Santander, Catatumbo area: Convention municipalities, El Carmen, El Tarra, Teorama, Sardinata, Tibu, El Zulia, Hacarí and San Calixto.

• The department of Chocó: Rio Sucio, Carmen del Darién, Juradó, Nuquí and Unguía.

• The department of Antioquia: Dabeiba, Mutatá, Turbo and Yondó.

The vaccine is not suitable for people with HIV, pregnant women and children under 6 months of age, among others. To visit nature parks or wilderness areas other vaccines, such as tetanus and hepatitis A and B are also recommended.

Visitors from countries offering a dengue vaccine should have it applied before traveling if visiting sites below 1,800 m.

Besides personal effects, each traveller is entitled to bring to Colombia money and goods free of duty and taxes under the following conditions:

US $ 10,000 or its equivalent in any currency. If the amount exceeds this, you must declare this income to the customsauthorities.

Family and non-commercial articles for personal use up to US$1,500, these items are tax free and must be included in he accompanied baggage.

Only in Bogota tap water can be drunk and used to prepare food. However, it should be clarified that the generalcondition of the pipes can not be guaranteed, therefore it is also necessary to take this information into account when consuming tap water. Other capital cities also have very good aqueduct services, with water that can be used to clean up. In rural areas and small cities it is advisable to buy bottled water or at points where it is treated.

The Conference Organising Committee or its agents will not be responsible for any medical expenses, loss or accidents incurred during the conference. Delegates are strongly advised to arrange their own personal insurance to cover medical and other expenses including accident or loss. Where a delegate has to cancel for medical reasons, the normal cancellation policy will apply.

32

COLOMBIA

WHAT TO PACK?

CLIMATE

ATM MACHINES

CURRENCY

VISAS AND PERMISSIONS

DEPARTURE TAX

TIPPING

SHOPPING

TIME ZONE

ELECTRIC POWER

Dress Code: Conference: Smart/Business casual.

A jacket and a scarf for the cold, Tennis for the tours, Valid passport, When you are with the Colombian migrationofficials, tell them that you are coming to an event. Bring the printed hotel reservation to show to the immigration officers.

Colombia is considered a country with tropical climate 356 days a year, without seasonal changes, with dry or rainy seasons depending on the region. You can find normal temperature of 14°C, 57°F.

Inside the Gran Estación Shopping Center you will find large ATMs such as Davivienda, Colpatria, Banco de Bogotá, BBVA, Bancolombia, Corpbanca and Servibanca.

At the hotel´s lobby you can also find ATM Machines of: Multired and Banco de Bogota.

Colombian Peso (COP).

Permanence in Colombia, without a visa, is allowed for tourism purposes up to 90 days, from the date of entry.

In the case of foreigners who are not resident in Colombia and have not exceeded 60 days in the country, these may complete the application procedure for issuing exemption at the Aerocivil modules set up for this purpose in internationalairports, where they will verify compliance with the requirement with the citizen’s passport, it will be stamped as a measure of control. If this certificate is presented to the airline at check- in time there no need to pay the tax. If foreign citizens stay in Colombia for more than 60 days, they must pay a departure tax averaging US$38 or $68,000 in total at the airline check-in desk.

If for some reason a departure tax on the ticket is paid and is subsequently granted the exemption, you must apply to the airline for reimbursement of the money, which must be returned before the trip.

Normally, the tip of the service will be included in the final value of the account.

10 minutes walking from the Grand Hyatt you can find the Gran Estación Shopping Center.

Time difference with Greenwich Meridian -5 Hours throughout the territory, all year long (UTC -5) Spain+7 hours, US/New York +1 hours, England +5 hours,Argentina and Brasil +2 hours, China +13 hours, México -1 hour.

110 volts of alternating current at 60 hertz (110V AC, 60Hz). American type electrical connectors, with two flat input pins.

41

SPONSORS

welcome message about isop · to the 19th annual meeting of the international society of...

Documents